I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 ...

Disclaimer: This content should not be considered as investment guidance. It is intended solely for informational purposes and does not constitute an offer, recommendation, endorsement, or any ...